Former Harvard Professor Charles Lieber Asks for No Prison Time Ahead of Sentencing, Citing Cancer Battle
As convicted ex-Harvard professor Charles M. Lieber awaits his sentencing hearing on Wednesday for lying to federal investigators about his ties to China, his attorneys asked a federal judge to spare him from prison, while prosecutors requested a 90-day sentence last week.
Charles M. Lieber, the Harvard chemistry professor convicted of lying to federal investigators in 2021, quietly retired last month, a Harvard spokesperson confirmed Tuesday.
Debate over the regulation of foreign money in academia, once an afterthought, has become a microcosm of the U.S.’s attempts to remain the world’s top innovator, exposing a tension between the government’s efforts to remain competitive and academia’s goals to promote innovation and the free flow of ideas.
Attorneys for Harvard professor Charles M. Lieber argued in court on Thursday that the renowned chemist’s December conviction should be overturned, alleging that the government failed to sufficiently prove its case.
The United States Department of Justice on Wednesday shuttered its controversial China Initiative, an anti-espionage crackdown that ensnared a top Harvard faculty member last year.
Attorneys for Harvard professor Charles M. Lieber filed a motion Monday for an acquittal or new trial, over a month after he was convicted in federal court on six felony counts.
University President Lawrence S. Bacow reiterated in a Thursday interview Harvard’s commitment to academic collaboration with foreign scholars following the federal conviction of Chemistry professor Charles M. Lieber.
Following Chemistry professor Charles M. Lieber’s conviction last month, Harvard scientists say they are “shocked” and “saddened” about the prolific research chemist's fall from grace — and apprehensive about the future of international scientific collaboration.
Harvard is not obligated to pay the legal fees of convicted Chemistry professor Charles M. Lieber, Massachusetts’s Supreme Judicial Court ruled Monday.
At Harvard, 2021 was a year marked by change. The school’s long-awaited return to in-person operations injected new life into a campus that had been left dormant for over a year by Covid-19. And in an unexpected shift, the University announced its intention to divest its endowment from fossil fuels after a decade of public pressure. Separately, faculty controversies — including a federal conviction and a high-profile departure — ignited debates that rippled across academia. Below, The Crimson looks back at the 10 stories that shaped the last year at Harvard.
Harvard professor Charles M. Lieber was found guilty of lying to government authorities about his ties to China in federal court on Tuesday, concluding a stunning downfall for one of the country’s top chemists.
Federal officials testified in court Monday that alleged false statements made by Harvard professor Charles M. Lieber prevented government authorities from fully exploring his ties to China.
Harvard professor Charles M. Lieber told the FBI in January 2020 that he “wasn’t completely transparent” in a separate interview with federal investigators two years prior, according to video of an interrogation presented in court by government prosecutors on Friday.
Defense attorneys representing Harvard professor Charles M. Lieber, who is facing trial for allegedly lying to federal investigators about his ties to China, sparred with prosecutors on Thursday over the evidentiary relevance of documents obtained during raids of the prominent chemist’s home and office.
Lawyers for Harvard professor Charles M. Lieber, who is accused of lying to federal investigators about his ties to China, mounted a dramatic defense of the renowned chemist in federal court Wednesday, calling the government’s proof against him “mangled” and “misguided.”
Former Harvard Chemistry chair Charles M. Lieber is set to stand trial Tuesday on six federal charges related to his ties to the Chinese government, nearly two years after his initial arrest.
As former Harvard Chemistry chair Charles M. Lieber goes on trial on federal charges beginning Tuesday, law and trade experts speculated that his case’s outcome could decide the fate of the Department of Justice’s China Initiative.